IP02-23: Duration of response to UGN-102 by age at baseline across 3 clinical trials in patients with low-grade intermediate-risk bladder cancer
Friday, May 15, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
146A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!